MiMedx Group, Inc. (MDXG)
4.57
-0.03
(-0.65%)
USD |
NASDAQ |
Sep 11, 16:00
4.565
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Market Cap : 665.96M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 665.96M |
| September 10, 2026 | 670.33M |
| September 09, 2026 | 681.99M |
| September 08, 2026 | 680.53M |
| September 04, 2026 | 665.96M |
| September 03, 2026 | 645.56M |
| September 02, 2026 | 663.05M |
| September 01, 2026 | 658.67M |
| August 31, 2026 | 661.59M |
| August 28, 2026 | 655.76M |
| August 27, 2026 | 657.22M |
| August 26, 2026 | 644.10M |
| August 25, 2026 | 632.44M |
| August 24, 2026 | 622.24M |
| August 21, 2026 | 630.99M |
| August 20, 2026 | 626.61M |
| August 19, 2026 | 648.47M |
| August 18, 2026 | 632.44M |
| August 17, 2026 | 610.59M |
| August 14, 2026 | 622.24M |
| August 13, 2026 | 612.04M |
| August 12, 2026 | 623.70M |
| August 11, 2026 | 629.53M |
| August 10, 2026 | 622.24M |
| August 07, 2026 | 632.44M |
| Date | Value |
|---|---|
| August 06, 2026 | 609.13M |
| August 05, 2026 | 606.21M |
| August 04, 2026 | 622.24M |
| August 03, 2026 | 622.24M |
| July 31, 2026 | 601.84M |
| July 30, 2026 | 622.24M |
| July 29, 2026 | 616.41M |
| July 28, 2026 | 635.36M |
| July 27, 2026 | 635.54M |
| July 24, 2026 | 625.51M |
| July 23, 2026 | 615.09M |
| July 22, 2026 | 621.04M |
| July 21, 2026 | 643.38M |
| July 20, 2026 | 644.87M |
| July 17, 2026 | 640.40M |
| July 16, 2026 | 659.77M |
| July 15, 2026 | 635.94M |
| July 14, 2026 | 625.51M |
| July 13, 2026 | 607.64M |
| July 10, 2026 | 612.11M |
| July 09, 2026 | 616.58M |
| July 08, 2026 | 634.45M |
| July 07, 2026 | 625.51M |
| July 06, 2026 | 606.15M |
| July 02, 2026 | 588.28M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anika Therapeutics, Inc. | 279.17M |
| Perspective Therapeutics, Inc. | 320.58M |
| ABVC BioPharma, Inc. | 25.25M |
| Enovis Corp. | 1.112B |
| Edwards Lifesciences Corp. | 48.65B |
Market Cap Related Metrics
| PE Ratio | 115.70 |
| PS Ratio | 1.918 |
| Price to Book Value | 3.083 |
| Price to Free Cash Flow | 16.09 |
| Price | 4.57 |
| Earnings Yield | 0.86% |
| Operating PE Ratio | 77.82 |
| Normalized PE Ratio | 115.99 |